You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Title |
A first in human, safety, pharmacokinetics, and clinical activity phase I study of once weekly administration of the Hsp90 inhibitor ganetespib (STA-9090) in patients with solid malignancies
|
---|---|
Published in |
BMC Cancer, March 2013
|
DOI | 10.1186/1471-2407-13-152 |
Pubmed ID | |
Authors |
Jonathan W Goldman, Robert N Raju, Gregory A Gordon, Iman El-Hariry, Florentina Teofilivici, Vojo M Vukovic, Robert Bradley, Michael D Karol, Yu Chen, Wei Guo, Takayo Inoue, Lee S Rosen |
Mendeley readers
The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 54 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 11 | 20% |
Student > Ph. D. Student | 10 | 19% |
Student > Doctoral Student | 6 | 11% |
Researcher | 6 | 11% |
Student > Master | 6 | 11% |
Other | 8 | 15% |
Unknown | 7 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 12 | 22% |
Agricultural and Biological Sciences | 11 | 20% |
Biochemistry, Genetics and Molecular Biology | 8 | 15% |
Chemistry | 4 | 7% |
Nursing and Health Professions | 3 | 6% |
Other | 9 | 17% |
Unknown | 7 | 13% |